The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes
Open accessAbstract
BACKGROUND: Poor neurodevelopmental outcomes and recurrences of cutaneous lesions remain unacceptably frequent among survivors of neonatal herpes simplex virus (HSV) disease. METHODS: We enrolled neonates with HSV disease in two parallel, identical, double-blind, placebo-controlled studies. Neonates with central nervous system (CNS) involvement were enrolled in one study, and neonates with skin, eye, and mouth involvement only were enrolled in the other. After completing a regimen of 14 to 21 days of parenteral acyclovir, the infants were randomly assigned to immediate acyclovir suppression (300 mg per square meter of body-surface area per dose orally, three times daily for 6 months) or placebo. Cutaneous recurrences were treated with open-label episodic therapy. RESULTS: A total of 74 neonates were enrolled--45 with CNS involvement and 29 with skin, eye, and mouth disease. The Mental Development Index of the Bayley Scales of Infant Development (in which scores range from 50 to 150, with a mean of 100 and with higher scores indicating better neurodevelopmental outcomes) was assessed in 28 of the 45 infants with CNS involvement (62%) at 12 months of age. After adjustment for covariates, infants with CNS involvement who had been randomly assigned to acyclovir suppression had significantly higher mean Bayley mental-development scores at 12 months than did infants randomly assigned to placebo (88.24 vs. 68.12, P=0.046). Overall, there was a trend toward more neutropenia in the acyclovir group than in the placebo group (P=0.09). CONCLUSIONS: Infants surviving neonatal HSV disease with CNS involvement had improved neurodevelopmental outcomes when they received suppressive therapy with oral acyclovir for 6 months. (Funded by the National Institute of Allergy and Infectious Diseases; CASG 103 and CASG 104 ClinicalTrials.gov numbers, NCT00031460 and NCT00031447, respectively.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Report of the Committee on Infectious Diseases
Nider, H. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670190156031 · Cited by 1,911
Whitley, R. J., Kimberlin, D. W., & Roizman, B. (1998) · Clinical Infectious Diseases · doi:10.1086/514600 · Cited by 1,149
Self-citationWhitley, R. J., & Roizman, B. (2002) · Wiley Encyclopedia of Molecular Medicine · doi:10.1002/0471203076.emm0597 · Cited by 700
Self-citationKimberlin, D. W., Lin, C.-Y., Jacobs, R. F., Powell, D. A., Corey, L., Gruber, W. C., Rathore, M., Bradley, J. S., Diaz, P. S., Kumar, M., et al. (2001) · Pediatrics · doi:10.1542/peds.108.2.230 · Cited by 574
Self-citationNatural History of Neonatal Herpes Simplex Virus Infections in the Acyclovir Era
Kimberlin, D. W., Lin, C.-Y., Jacobs, R. F., Powell, D. A., Frenkel, L. M., Gruber, W. C., Rathore, M., Bradley, J. S., Diaz, P. S., Kumar, M., et al. (2001) · Pediatrics · doi:10.1542/peds.108.2.223 · Cited by 507
Self-citationA Controlled Trial Comparing Vidarabine with Acyclovir in Neonatal Herpes Simplex Virus Infection
Whitley, R., Arvin, A., Prober, C., Burchett, S., Corey, L., Powell, D., Plotkin, S., Starr, S., Alford, C., Connor, J., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102143240703 · Cited by 388
Self-citationVidarabine Therapy of Neonatal Herpes Simplex Virus Infection
Whitley, R. J., Nahmias, A. J., Soong, S.-J., Galasso, G. G., Fleming, C. L., Alford, C. A., Connor, J., Bryson, Y., & Linnemann, C. (1980) · Pediatrics · doi:10.1542/peds.66.4.495 · Cited by 358
Self-citationDouglas, J. M., Critchlow, C., Benedetti, J., Mertz, G. J., Connor, J. D., Hintz, M. A., Fahnlander, A., Remington, M., Winter, C., & Corey, L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406143102402 · Cited by 337
Reitano, M., Tyring, S., Lang, W., Thoming, C., Worm, A. ‐., Borelli, S., Chambers, L. O., Robinson, J. M., Corey, L., & the International Valaciclovir HSV Study Group (1998) · The Journal of Infectious Diseases · doi:10.1086/515385 · Cited by 209
Self-citationKimberlin, D. W., & Rouse, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmcp023065 · Cited by 168
Self-citation
Cited by
Shane, A. L., Sánchez, P. J., & Stoll, B. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31002-4 · Cited by 1,226
Self-citationSimonsen, K. A., Anderson-Berry, A. L., Delair, S. F., & Davies, H. D. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00031-13 · Cited by 984
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53488-0.00011-0 · Cited by 474
Pathogenesis and virulence of herpes simplex virus
Zhu, S., & Viejo-Borbolla, A. (2021) · Virulence · doi:10.1080/21505594.2021.1982373 · Cited by 376
Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer’s Disease
Itzhaki, R. F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00324 · Cited by 256
Metadata
- Authors
- Kimberlin, D. W., Whitley, R. J., Wan, W., Powell, D. A., Storch, G., Ahmed, A., Palmer, A., Sánchez, P. J., Jacobs, R. F., Bradley, J. S., Robinson, J. L., Shelton, M., Dennehy, P. H., Leach, C., Rathore, M., Abughali, N., Wright, P., Frenkel, L. M., Brady, R. C., Van Dyke, R., Weiner, L. B., Guzman-Cottrill, J., McCarthy, C. A., Griffin, J., Jester, P., Parker, M., Lakeman, F. D., Kuo, H., Lee, C. H., & Cloud, G. A.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2011-10-06
- Volume
- 365
- Issue
- 14
- Pages
- 1284-1292
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2151279983
- Cited by
- 322
- References
- 19
- FWCI
- 19.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes. https://app.cochat.ai/papers/10.1056/nejmoa1003509
- The paper
- Kimberlin, D. W., Whitley, R. J., Wan, W., Powell, D. A., Storch, G., Ahmed, A., Palmer, A., Sánchez, P. J., Jacobs, R. F., Bradley, J. S., Robinson, J. L., Shelton, M., Dennehy, P. H., Leach, C., Rathore, M., Abughali, N., Wright, P., Frenkel, L. M., Brady, R. C., . . . Cloud, G. A. (2011). Oral Acyclovir Suppression and Neurodevelopment after Neonatal Herpes. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1003509
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.